DETECT: Detection of Local Field Potentials in the Ventral Tegmental Area of the Midbrain in Chronic Cluster Headache Patients

Sponsor
Assistance Publique Hopitaux De Marseille (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05857098
Collaborator
(none)
5
1
24
0.2

Study Details

Study Description

Brief Summary

The physiopathology of trigeminal-autonomic cephalalgia, and more particularly of cluster headache (CH) is still partially unknown. Three main structures are involved: the trigeminovascular system, the cephalic afferents of the autonomic nervous system, and centrally the hypothalamus. There are many clinical arguments in favor of the involvement of the hypothalamus in CH. In addition, several radiological studies have confirmed the involvement of the posterior hypothalamic region in cluster attacks. Thus, a positron emission tomography study showed hyperactivity of the posteroinferior nucleus of the ipsilateral hypothalamus. Voxel based MRI studies have shown a bilateral increase in the volume of the inferoposterior part of the homolateral hypothalamus. The involvement of the posterior hypothalamic region or more precisely the ventral tegmental area of the midbrain therefore seems acquired, although its real role as a generator or modulator of pain remains to be precised.

Deep brain stimulation (dBS) is used in the management of chronic drug-resistant CH with an overall efficacy in 2/3 of patients. Nevertheless, its mechanism of action remains poorly understood, thus limiting the selection of patients and the optimization of care. The lack of clear neurophysiological criteria to identify the neuronal population to be targeted is a major source of uncertainty in the positioning of dBS electrodes and parameters adjustment. In order to improve the understanding and at the same time the results of this technique, obtaining in vivo electrophysiological data seems mandatory. Local fields potentials (LFP) have been recordered by in vivo by dBS in other diseases (Parkinson's disease, tremor…) and their analysis has brought new insigights in the characterization and understanding of these pathology. New generations of neurostimulator (Percept Medtronic) enables continuous recording of LFP in implanted patients. The goal of our study is the recording of LFP at the time of CH attacks via the BrainSenseTM system. This system included in the stimulator allows in vivo collection of LFP in the absence and presence of stimulation. The pathophysiological data recordered will then be correlated with the clinical benefit of the dBS ( nulber of attacks, duration, pain intensity…). As it is a feasibility study, only 5 patients will be included.

Condition or Disease Intervention/Treatment Phase
  • Other: Local Field potential recording

Study Design

Study Type:
Observational
Anticipated Enrollment :
5 participants
Observational Model:
Other
Time Perspective:
Prospective
Official Title:
Detection of Local Field Potentials in the Ventral Tegmental Area of the Midbrain in Chronic Cluster Headache Patients Treated by Deep Brain Stimulation : a Feasibility Study
Anticipated Study Start Date :
May 31, 2023
Anticipated Primary Completion Date :
Jun 1, 2025
Anticipated Study Completion Date :
Jun 1, 2025

Outcome Measures

Primary Outcome Measures

  1. Change in Local field potentials [Between 0 to 12 months]

    Local field potentials amplitudes registered by the patient during a cluster attack

Secondary Outcome Measures

  1. Change in Efficacy of deep brain stimulation on attacks frequency [Between 0 to 12 months]

    Frequency of cluster attacks

  2. Change in Efficacy of deep brain stimulation on pain intensity [Between 0 to 12 months]

    Pain intensity of cluster attacks

  3. Change Efficacy of deep brain stimulation in attacks duration [Between 0 to 12 months]

    Duration of cluster attacks

  4. Change in Efficacy of deep brain stimulation on treatment [Between 0 to 12 months]

    Medical treatments for cluster headache

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Adult patients (age : 18-70 years-old) suffering from refractory chronic cluster headache

  • Patients eligible for a deep brain stimulation in the ventral tegmental area of the mesencephalon

  • Patients implanted with a deep brain stimulation system PerceptTM Medtronic®

Exclusion Criteria:
  • Secondary cluster headache

  • Patients implanted with another device of deep brain stimulation

Contacts and Locations

Locations

Site City State Country Postal Code
1 Assistance Publique Hopitaux de Marseille Marseille France

Sponsors and Collaborators

  • Assistance Publique Hopitaux De Marseille

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier:
NCT05857098
Other Study ID Numbers:
  • RCAPHM23_0056
First Posted:
May 12, 2023
Last Update Posted:
May 12, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Assistance Publique Hopitaux De Marseille
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 12, 2023